RENAL-LIMITED THROMBOTIC MICROANGIOPATHY

This adverse event was reported 230 times

These drugs are most commonly taken by patients reporting RENAL-LIMITED THROMBOTIC MICROANGIOPATHY:

# Drug Count
0 BEVACIZUMAB 51
1 TACROLIMUS 38
2 TACROLIMUS EXTENDED-RELEASE CAPSULES 36
3 TACROLIMUS OINTMENT 0.1% 36
4 DOXORUBICIN 34
5 GEMCITABINE HYDROCHLORIDE 31
6 PREDNISONE 28
7 MYCOPHENOLIC ACID 27
8 MYCOPHENILIC ACID 25
9 GEMCITABINE 21
See all common drugs associated with RENAL-LIMITED THROMBOTIC MICROANGIOPATHY

RENAL-LIMITED THROMBOTIC MICROANGIOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DUVELISIB 4 0.0047
1 TREOSULFAN 6 0.0022
2 CIDOFOVIR ANHYDROUS 3 0.0021
3 SIROLIMUS 17 0.0012
4 MYCOPHENILIC ACID 25 0.0012
5 BASILIXIMAB 13 0.0011
6 BELATACEPT 5 0.0011
7 FRUQUINTINIB 4 0.0010
8 FOSNETUPITANT AND PALONOSETRON 1 0.0008
9 NETUPITANT AND PALONOSETRON 1 0.0008
See all drugs enriched for association with RENAL-LIMITED THROMBOTIC MICROANGIOPATHY